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Abstract: Background/Aims Small intestinal bacterial overgrowth (SIBO) is a common condition in
disorders of gut-brain interaction (DGBI). Recently, a combined scintigraphy-lactulose hydrogen breath
test (ScLHBT) was described as an accurate tool diagnosing SIBO. We aim to analyze whether a lactulose
nutrient challenge test (NCT), previously shown to separate DGBI from healthy volunteers, is equivalent
to ScLHBT in diagnosing SIBO. Methods We studied data of 81 DGBI patients undergoing ScLHBT
with 30 g lactulose and 300 mL water as well as NCT with 30 g lactulose and a 400 mL liquid test
meal. Differences in proportion of positive SIBO diagnoses according to specified cecal load and time
criteria for NCT and ScLHBT, respectively, were tested in an equivalence trial. An odds ratio (OR)
range of 0.80-1.25 was considered equivalent. Results Diagnosis of SIBO during NCT was not equivalent
to SIBO diagnosis in ScLHBT, considering a hydrogen increase before cecal load of 5.0%, 7.5%, or 10.0%,
respectively ([OR, 3.76; 90% CI, 1.99-7.09], [OR, 1.87; 90% CI, 1.06-3.27], and [OR, 1.11; 90% CI, 0.65-
1.89]). Considering only time to hydrogen increase as criterion, the odds of a positive SIBO diagnosis
in the NCT (0.65) was lower than in ScLHBT (1.70) (OR, 0.38; 90% CI, 0.23-0.65). Conclusions This
study could not show an equivalence of NCT and ScLHBT in diagnosing SIBO. A possible explanation
might be the different transit times owing to unequal testing substances. The effect of this deviation in
relation to consecutive therapy regimens should be tested in further prospective studies.
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Background/Aims
Small intestinal bacterial overgrowth (SIBO) is a common condition in disorders of gut-brain interaction (DGBI). Recently, a combined 
scintigraphy–lactulose hydrogen breath test (ScLHBT) was described as an accurate tool diagnosing SIBO. We aim to analyze whether 
a lactulose nutrient challenge test (NCT), previously shown to separate DGBI from healthy volunteers, is equivalent to ScLHBT in 
diagnosing SIBO.
Methods
We studied data of 81 DGBI patients undergoing ScLHBT with 30 g lactulose and 300 mL water as well as NCT with 30 g lactulose 
and a 400 mL liquid test meal. Differences in proportion of positive SIBO diagnoses according to specified cecal load and time 
criteria for NCT and ScLHBT, respectively, were tested in an equivalence trial. An odds ratio (OR) range of 0.80-1.25 was considered 
equivalent.
Results
Diagnosis of SIBO during NCT was not equivalent to SIBO diagnosis in ScLHBT, considering a hydrogen increase before cecal load 
of 5.0%, 7.5%, or 10.0%, respectively ([OR, 3.76; 90% CI, 1.99-7.09], [OR, 1.87; 90% CI, 1.06-3.27], and [OR, 1.11; 90% CI, 0.65-
1.89]). Considering only time to hydrogen increase as criterion, the odds of a positive SIBO diagnosis in the NCT (0.65) was lower than 
in ScLHBT (1.70) (OR, 0.38; 90% CI, 0.23-0.65).
Conclusions
This study could not show an equivalence of NCT and ScLHBT in diagnosing SIBO. A possible explanation might be the different transit 
times owing to unequal testing substances. The effect of this deviation in relation to consecutive therapy regimens should be tested in 
further prospective studies. 
(J Neurogastroenterol Motil 2020;26:514-520)
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Introduction  
Hydrogen based breath tests have been employed for a sub-
stantial time using a myriad of substances and protocols. However, 
if done correctly, they are a useful, safe and cost-effective diagnostic 
adjunct in the evaluation of gastrointestinal problems.1 Particularly 
in small intestinal bacterial overgrowth (SIBO), lactulose and glu-
cose breath tests represent widely used non-invasive alternatives 
to other SIBO diagnostics.1,2 In disorders of gut-brain interaction 
(DGBI), SIBO is a frequently mentioned condition, with a report-
ed prevalence of 38-54% in patients with irritable bowel syndrome 
(IBS) tested by lactulose hydrogen breath test (LHBT).3,4 Accord-
ingly, a significant improvement of abdominal symptoms was shown 
in response to antibiotic treatment in an IBS cohort with high SIBO 
prevalence.5 This finding was underlined by 2 identically designed, 
phase 3, double-blinded placebo-controlled trials with a non-
absorbable antibiotic in non-constipated IBS patients.6 However, 
this study did not focus on the mechanism of effect and the bacterial 
eradication was not based on a prior SIBO diagnosis. Even though 
standardization of SIBO diagnostics has been proposed, there is 
still significant heterogeneity in how the test is performed. By many 
researchers, aspiration of small bowel fluid, culturing and quantifi-
cation of bacteria is regarded gold standard for diagnosing SIBO.7 
However, this procedure is time-consuming, expensive, invasive, 
and limited to the proximal small bowel,1 thereby missing SIBO in 
the distal part of the small bowel. A study by Zhao et al8 introduced 
combined scintigraphy–LHBT (ScLHBT) as an accurate and 
reproducible diagnostic test for SIBO. Scintigraphy involves radia-
tion exposure, a dedicated infrastructure, and is very expensive. The 
cost of LHBTs depends on local reimbursement but is in the range 
of 10-20% of scintigraphies. While different studies investigated 
LHBT in diagnosing SIBO, there is no published data in the use 
of nutrient challenge tests (NCT), consisting of a standardized 
liquid test meal in combination with a standard LHBT.9 How-
ever, performing a NCT, originally developed to discriminate IBS 
patients from healthy volunteers, was recently shown to be useful 
in discriminating healthy volunteers from subjects with functional 
dyspepsia (FD), potentially expanding its range of applications.9-11 
In this study we aim to analyze whether the NCT, as a cost-effective 
and radiation-free alternative to scintigraphy, is equivalent to the 
ScLHBT in diagnosing SIBO.
Materials and Methods  
In this retrospective study data of 81 consecutive DGBI pa-
tients treated at our academic tertiary gastrointestinal center with 
signed informed consent to the use of their health-related data for 
scientific purposes were analyzed. Inclusion criteria were age (older 
than 18 years) and complete testings for SIBO by NCT as well as 
ScLHBT between July 2014 and April 2018. All patients under-
went both tests. ScLHBT to test for SIBO and NCT in the clinical 
setting primarily to test for food/fermentable oligo-, di-, monosac-
charides, and polyols (FODMAP) intolerance and secondarily (the 
not yet proven) SIBO diagnostic analyzed in this study. The study 
was approved by the local ethical committee (BASEC number 
2016-01931).
Nutrient Challenge Test
For the NCT, patients consumed 30 g lactulose combined with 
400 mL Ensure (600 kcal, 20 g fat, 81 g carbohydrates, and 25 g 
protein) after overnight fasting. Every 10 minutes and for a total 
duration of 180 minutes, hydrogen breath levels were measured and 
5 abdominal symptoms (bloating, pain, bowel sounds, diarrhea, and 
nausea) were recorded using a 5-point Likert-like scale. Hydrogen 
levels were measured by Breathalyzer-HydroCheck (NEOMED 
System, Adelhausen, Germany). During NCT SIBO was diag-
nosed if hydrogen levels increased by more than 10 parts per million 
(ppm) in 2 consecutive measurements compared to baseline within 
20-90 minutes after ingestion. Patients with no hydrogen increase 
or not higher than 10 ppm for 180 minutes were considered “hy-
drogen non-producers.”
Combined Scintigraphy With Lactulose Hydrogen 
Breath Test
For the ScLHBT, patients consumed 30 g lactulose in 300 
mL water after overnight fasting. Different criteria for abnormal 
LHBT and ScLHBTs are used to date. Previous findings dem-
onstrated 5% cecal load (CL)8,12,13 as well as 10% CL14,15 to be 
useful markers of abnormal ScLHBT. We therefore tested differ-
ent criteria to diagnose SIBO. The first 3 criteria were based on 
the CL: SIBO was diagnosed if hydrogen increased more than 10 
ppm in 2 consecutive measurements compared to baseline before 
the detection of 5.0%, 7.5%, or 10.0% cecal activity (99mtechnetium 
diethylene-triamine-pentaacetate (99mTc-DTPA) in scintigraphy. All 
scintigraphic measurements were analyzed by an experienced spe-
cialist in nuclear medicine. As a fourth criterion, hydrogen increase 
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by more than 10 ppm in 2 consecutive measurements compared to 
baseline within 20-90 minutes after ingestion, was used (comparable 
to the NCT analysis). Hydrogen levels were measured by Breath-
alyzer-HydroCheck (NEOMED System). Statistical analyses 
were performed for all 4 SIBO ScLHBT criteria and compared to 
SIBO proportions in NCT. Patients with no hydrogen increase or 
not higher than 10 ppm for 180 minutes were considered “hydrogen 
non-producers.”
In a subgroup analysis we analyzed data of ScLHBT only to 
check for equivalence of the different diagnostic criteria used in 
ScLHBT: we tested for equivalence of a clinically significant hydro-
gen increase by 90 minutes as compared to the hydrogen increase 
by scintigraphy-controlled CL as well as for equivalence of abdomi-
nal symptom generation.
Disorders of Gut-Brain Interaction 
Diagnosis of DGBI and DGBI subcategories IBS, IBS-FD 
overlap, FD, and functional abdominal pain or bloating (FAPB) 
were defined according to Rome III and IV criteria.16,17 
Statistical Methods
A sample size calculation for equivalence testing in proportions 
according to Chow and Shao18 indicated that at least 78 patients 
in each group would be needed to demonstrate an equivalence of 
SIBO proportions diagnosed in NCT compared to ScLHBT 
with an 80% power and an alpha of 0.05. To visualize distribution 
of absolute hydrogen values and hydrogen differences, normal 
quantile-quantile plots were used. Two different statistical methods 
were used to analyze equivalence of SIBO diagnostics: on the one 
hand odds ratio (OR) and on the other hand analysis of data from 
matched samples with dichotomous outcome according to Fleiss et 
al19 were used to assess whether NCT is equivalent to ScLHBT in 
diagnosing SIBO. An OR range between 0.80 and 1.25 was con-
sidered equivalent.20 Conversion to equivalence margin in analysis 
of data from matched samples with dichotomous outcome resulted 
in a ΔP of ± 0.05 (for detailed calculations see Supplementary 
Table). Hence, the equivalence margin for matched samples analy-
ses was set at ± 0.05. For continuous variables, median and range 
were used for non-normally distributed data. To compare this 
data, Wilcoxon rank sum tests were used. For categorical data, chi-
squared and Fisher’s exact test were used. Statistical analyses were 
performed with R version 3.5.2 (R Foundation for Statistical Com-











































Different testing methods for SIBO diagnoses
SIBO +
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Figure 1. Proportions of positive small intestine bacterial overgrowth 
(SIBO) diagnosis. NCT: SIBO diagnosis in nutrient challenge test. 
Combined scintigraphy lactulose hydrogen breath test (ScLHBT) 
5.0% cecal load (CL), 7.5% CL, and 10.0% CL: SIBO positive 
if more than 10 ppm hydrogen increase from baseline in at least 2 
consecutive measurements before detected CL of 5.0%, 7.5%, and 
10.0%. ScLHBT time: SIBO positive if more than 10 ppm hydrogen 
increase from baseline in at least 2 consecutive measurements by 90 































Figure 2. Equivalence testing of small intestine bacterial overgrowth 
(SIBO) diagnosis in nutrient challenge test (NCT) and different cri-
teria in combined scintigraphy lactulose hydrogen breath test, accord-
ing to Fleiss et al.19 SIBO was diagnosed if hydrogen increased more 
than 10 parts per million (ppm) in 2 consecutive measurements com-
pared to baseline before the detection of 5.0% (5.0% cecal load [CL]), 
7.5% (7.5% CL), or 10.0% (10.0% CL) cecal activity in scintigraphy. 
During NCT SIBO was diagnosed if hydrogen levels increased by 
more than 10 ppm in 2 consecutive measurements compared to base-
line within 20-90 minutes after ingestion. Horizontal lines represent-
ing 90% confidence interval (CI). Vertical dotted lines representing 
upper (0.05) and lower (–0.05) equivalence limit. Equivalence is giv-
en if 90% CI (horizontal line) does not exceed any of the equivalence 
margins (vertical dotted lines). CL, cecal load.
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Results  
Eighty-one patients were included in the analysis (men, 18/81 
[22.2%]; median age, 39 years [range 19-70 years]). The me-
dian body weight was 60 kg (range, 43-102 kg). All patients suf-
fered from DGBI. IBS was the most prevalent subtype (n = 33, 
40.7%), followed by IBS-FD overlap (n = 30, 37.0%), FD (n = 
9, 11.1%), and FAPB (n = 9, 11.1%). Of all IBS patients 13 were 
diagnosed with IBS with constipation, 10 with IBS with diarrhea, 7 
with IBS mixed type, and 3 with unclassified IBS.
Small Intestinal Bacterial Overgrowth Diagnoses
Small intestinal bacterial overgrowth diagnosis by time 
criterion
SIBO was diagnosed in 32/81 (39.5%) patients with NCT and 
51/81 (63.0%) patients with ScLHBT using SIBO diagnostic cri-
teria of more than 10 ppm hydrogen increase as compared to base-
line within 20-90 minutes after the intake of the testing substance. 
Difference in proportions was –0.23 (90% CI, –0.34-–0.12], 
failing to show equivalence between the 2 tests since the 90% CI 
exceeds equivalence margins of ± 0.05
Small intestinal bacterial overgrowth diagnosis by cecal 
load 5.0% criterion
Based on 5.0% CL measurement in ScLHBT, 32/81 subjects 
(39.5%) were diagnosed with SIBO by ScLHBT, in contrast only 
12/81 (14.8%) subjects were tested positive with NCT in the same 
subgroup. Difference in proportions was 0.25 (90% CI, 0.12-0.37). 
No equivalence was shown (Fig. 1 and 2). 
Small intestinal bacterial overgrowth diagnosis by cecal 
load 7.5% criterion
Based on the criterion of 7.5% CL in ScLHBT, SIBO was di-
agnosed in 21/81 (25.9%) subjects with NCT and in 32/81 subjects 
(39.5%) with ScLHBT, resulting in a difference of proportions of 
0.14 (90% CI, 0.01-0.26). No equivalence was shown (Fig. 1 and 2). 
SIBO diagnosis by cecal load 10.0% criterion
Based on the 10.0% CL measurements, 30/81 patients (37.0%) 
were diagnosed with SIBO with NCT and 32/81 (39.5%) with 
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Figure 4. Equivalence plot of odds ratio (OR) in small intestine bac-
terial overgrowth findings in combined scintigraphy lactulose hydro-
gen breath test (ScLHBT) by time criterion and different cecal load 
(CL) criteria. Time criterion (hydrogen increase > 10 ppm in at least 
2 consecutive measurements by 90 minutes) in ScLHBT vs 10 ppm 
hydrogen increase from baseline in at least 2 consecutive measure-
ments before detected CL of 5.0%, 7.5%, and 10.0%). Horizontal 
lines representing 90% confidence interval (CI). Vertical dotted lines 
representing upper (1.25) and lower (0.80) equivalence limit. Equiva-
lence is given if 90% CI (horizontal line) does not exceed any of the 
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Figure 3. Equivalence plot of odds ratio (OR) in small intestine bac-
terial overgrowth (SIBO) findings in nutrient challenge test (NCT) 
and different criteria of combined scintigraphy lactulose hydrogen 
breath test. SIBO was diagnosed if hydrogen increased more than 10 
parts per million (ppm) in 2 consecutive measurements compared to 
baseline before the detection of 5.0% (cecal load [CL] 5.0%), 7.5% 
(CL 7.5%), or 10.0% (CL 10.0%) cecal activity in scintigraphy. Dur-
ing NCT SIBO was diagnosed if hydrogen levels increased by more 
than 10 ppm in 2 consecutive measurements compared to baseline 
within 20-90 minutes after ingestion. Horizontal lines representing 
90% confidence interval (CI). Vertical dotted lines representing upper 
(1.25) and lower (0.80) equivalence limit. Equivalence is given if 90% 
CI (horizontal line) does not exceed any of the equivalence margins 
(vertical dotted lines). CL, cecal load.
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0.15). No equivalence was shown (Fig. 1 and 2). 
Odds Ratio
Time criterion
The odds of positive SIBO testing in NCT (0.65) was lower 
than in ScLHBT (1.70) based on time criteria (OR, 0.38; 90% CI, 
0.23-0.65), therefore failing to confirm equivalence.
Cecal load 5.0% criterion
The odds of positive SIBO testing by CL 5.0% criterion was 
higher in NCT (0.65) than in ScLHBT (0.17) (OR, 3.76; 90% 
CI, (1.99-7.09). Equivalence was not confirmed (Fig. 3). 
Cecal load 7.5% criterion
In the 7.5% CL measurements, odds of positive SIBO result 
was higher in NCT (0.65) than in ScLHBT (0.35) (OR, 1.87; 
90% CI, 1.06-3.27). Equivalence was not shown (Fig. 3). 
Cecal load 10.0% criterion
In the 10.0% CL measurements, the odds of positive SIBO 
testing was higher in NCT (0.65) than in ScLHBT (0.59) (OR, 
1.11; 90% CI, 0.65-1.89). Equivalence was not shown (Fig. 3). 
Subanalysis: Significant Hydrogen Increase
The first hydrogen increase > 10 ppm in at least 2 consecu-
tive measures occurred at a median of 50 minutes (range 20-170 
minutes) in NCT and at 70 minutes (range 20-160 minutes) in 
ScLHBT. Median CL at clinically significant hydrogen increase in 
ScLHBT was 9.0% (range 0.0-16.0%). In NCT, a total of 35 pa-
tients (43.2%) were hydrogen non-producers while there were only 
20 hydrogen non-producers (24.7%) in ScLHBT. 
Subanalysis: Significant Symptom Increase
The first clinically significant median increase (= increase of 
at least 1 point on Likert scale in 2 consecutive measurements) 
of bloating occurred at 30 minutes (20-170 minutes) with NCT, 
and at 40 minutes (20-140 minutes) with ScLHBT (P = 0.535). 
Abdominal pain significantly increased at 30 minutes (20-180 
minutes) with NCT, and at 50 minutes (20-160 minutes) with 
ScLHBT (P = 0.078). Clinically significant nausea occurred after 
a median observation time of 20 minutes (20-120 minutes) and 30 
minutes (20-180 minutes) (P = 0.007), borborygmi at 30 minutes 
(20-170 minutes) and 40 minutes (20-180 minutes) (P = 0.048), 
and diarrhea at 80 minutes (20-180 minutes) and 80 minutes (20-
170 minutes) (P = 0.119) in NCT and ScLHBT, respectively.
Subanalysis: Scintigraphy−Lactulose Hydrogen 
Breath Test Only
Analyzing the results within ScLHBT itself was superior to the 
prevalence of SIBO by time criterion as compared to scintigraphy-
controlled analysis (Fig. 1 and 4). 
Discussion  
This study did not confirm an equivalence in diagnosing SIBO 
by NCT as compared to ScLHBT. While NCT was proven to be 
a good non-invasive test to discriminate IBS and FD patients from 
healthy volunteers,11 its role in diagnosing SIBO is not established 
yet. One reason for the non-equivalence of NCT and ScLHBT 
may be based on the 2 different testing substances entailing differ-
ent orocecal transit times (OCTT). This difference may be caused 
by the delayed gastric emptying after addition of a liquid test meal 
in NCT on the one hand, in contrast to an increased small bowel 
transit time due to the application of lactulose only on the other 
hand.15 An additional cause for lower rates of SIBO by ScLHBT 
(based on CL) might be the slight delay of hydrogen increase as 
compared to imaging of CL. Bond et al13 showed a 5-8 minute 
delay in hydrogen increase due to fermentation time of lactulose, 
hydrogen absorption to the blood, and final pulmonary excretion of 
hydrogen. The later hydrogen increase was also confirmed by Yu 
et al.12 They found that in 22 out of 25 (88.0%) IBS patients the 
hydrogen increase occurred later than the 99mTc reached the cecum. 
However, in contrast to our study, they considered a hydrogen in-
crease of > 20 ppm as clinically significant. Read et al21 could dem-
onstrate that (0.5 g and 5 g boluses of) lactulose infused directly into 
the colon resulted in a significant hydrogen increase of 5-10 ppm 
within a few minutes. According to this and in line with the study of 
Esposito et al,22 we used 10 ppm (in 2 consecutive measurements) 
by 90 minutes as a marker of abnormal LHBT/ScLHBT in order 
to increase sensitivity and decrease false negative SIBO results.
To date, a broad range of diagnostic criteria for abnormal 
LHBT and ScLHBTs are used. Previous findings demonstrated 
5.0% CL accumulation8,12,13 and 10.0% accumulation14,15 to be use-
ful markers of abnormal ScLHBT. We therefore analyzed data for 
5.0%, 10.0%, as well as 7.5% cecal load, showing the largest dis-
crepancy of equivalent SIBO proportions at 5.0%, followed by 7.5% 
and 10.0%. This is also in line with the hypothesis of the slower 
OCTT in the NCT containing the liquid test meal. 
However, in this study there are some limitations: We found a 
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high prevalence of hydrogen non-producers. In NCT, the preva-
lence of hydrogen non-producers was as high as 43.0%, compared 
to 25.0% in ScLHBT. This fact complicates the interpretation 
of SIBO diagnostics. Although this comparably high number of 
hydrogen non-producers is in line with reports from earlier stud-
ies,23,24 it is a limitation of our study cohort with regard to equiva-
lence testing. A second limitation might be the heterogenous patient 
cohort including IBS as well as FD and functional abdominal pain 
and bloating patients. However, we do assume that this did not 
substantially influence our results since the 2 tests were performed 
in the same patient cohort. Additionally, a majority of our study 
subjects suffered from IBS or IBS-FD overlap, the most frequently 
investigated DGBI diagnoses in SIBO studies.6,25,26 However, the 
association and impact of SIBO in DGBI patients remains con-
troversial. While a significant reduction of global IBS symptoms 
could be shown after therapy with Rifaximin in a previous study,6 
no preselection of SIBO diagnosis was performed there. A preced-
ing study could though show a normalization of a LHBT after 
antibiotic therapy in IBS patients.27 They used a hydrogen increase 
before 90 minutes and secondary, the originally traditional but not 
well validated 2 peaks as diagnostic criteria, which both were used 
for SIBO diagnostics by other studies. Despite these studies show-
ing significant impact of antibiotic therapies on abdominal burdens 
in DGBI patients, the direct association between SIBO and DGBI 
is not clear, as there may be different effect mechanism: by affect-
ing gut bacteria gas production might be reduced and therefore 
directly decrease symptoms or indirectly reduce immune response 
or both. However, whether it is directly linked to SIBO, including 
its controversially discussed testing methods, is not yet confirmed. 
The additional fact that in our study we analyzed SIBO itself in as-
sociation with a not clearly validated diagnostic gold standard, but 
though as compared to ScLHBT, which represents an accurate test 
for SIBO diagnostics, may represent a limitation. In a subanalysis 
of SIBO diagnosis according to hydrogen increase by 90 minutes 
as compared to scintigraphic criteria, we could not confirm equiva-
lence either. This finding is in line with the findings of Yu et al,12 
who demonstrated a discordance of positive LHBT and ScLHBT 
results. They even argued that abnormal LHBT tests rather rep-
resent OCTT than SIBO. However, a few years later in the North 
American Consensus, based on a pooled positivity rate of LHBT 
or glucose breath test including 19 studies with a total of 888 study 
subjects, LHBT was regarded as a valuable non-invasive alterna-
tive for diagnosing SIBO. 
In contrast to our study, most of the studies used LHBT with-
out an additional test meal. However, to better represent physiologi-
cal conditions and because the NCT was shown useful to discrimi-
nate IBS and FD patients from healthy volunteers,9-11 we used the 
NCT. The test meal might also explain the significant differences in 
the occurrence of nausea and borborygmi. Farré et al28 demonstrat-
ed that in FD patients particularly postprandial distension thresh-
olds are associated with the severity of meal-related symptom gen-
eration. Additionally, increased visceral sensitivity was shown in FD 
and IBS patients after nutrient infusion.29-31 In our study, besides 
a significant difference in nausea and borborygmi, abdominal pain 
tended to occur earlier in NCT too. We attribute this to the visceral 
hypersensitivity in particular to nutrients and volume distension in 
an additional test meal (NCT), as compared to lactulose only (ScL-
HBT) in DGBI patients. With regard to diarrhea, no significant 
difference was seen, which is probably due to the low overall preva-
lence of diarrhea in our cohort. However, the earlier symptom gen-
eration in NCT in contrast to the later hydrogen increase leads to 
the assumption that rather the substance of consumption (test meal 
and lactulose vs lactulose only) than the hydrogen increase or SIBO 
diagnosis alone influences symptom generation in DGBI patients. 
In addition to the different abdominal symptom generation, 
the main hypothesis of an equivalent proportion of SIBO diagnosis 
in NCT as compared to ScLHBT could not be confirmed. This 
leads us to the assumption that the less expensive and radiation-free 
NCTs cannot replace ScLHBT, independent of the criteria used 
for diagnosing SIBO. Whether and to what extent this influences 
SIBO therapies, in particular antibiotic therapies, in FIGD patients 
remains unclear. Further prospective and multicenter studies based 
on therapies and outcomes according to NCT as compared to ScL-
HBT test results are desirable. 
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